LORBRENA
LORBRENA
Approved
DIN Number
02485966
Drug Class
Human
Market Date
Apr 22, 2019
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02485966
AIG Number0161231001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01ED05 LORLATINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LORLATINIBActive
Strength: 25 MG
Monograph: LORLATINIB